Clinical outcomes after combination treatment with ceftazidime/avibactam and aztreonam for NDM-1/OXA-48/CTX-M-15-producing Klebsiella pneumoniae infection
Author(s) -
Evelyn Shaw,
Alexander Rombauts,
Fé Tubau,
Ariadna Padullés,
Jordi Càmara,
Toni Lozano,
Sara CoboSacristán,
Núria Sabé,
Inmaculada Grau,
Raúl RigoBonnin,
M.Á. Domínguez,
Jordi Carratalà
Publication year - 2017
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkx496
Subject(s) - ceftazidime/avibactam , aztreonam , klebsiella pneumoniae , ceftazidime , microbiology and biotechnology , medicine , avibactam , klebsiella , antibiotics , biology , bacteria , pseudomonas aeruginosa , antibiotic resistance , escherichia coli , imipenem , biochemistry , genetics , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom